UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:March 31,
ASLAN Pharmaceuticals (NASDAQ:ASLN)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025 Click aqui para mais gráficos ASLAN Pharmaceuticals.
ASLAN Pharmaceuticals (NASDAQ:ASLN)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025 Click aqui para mais gráficos ASLAN Pharmaceuticals.

Notícias Aslan Pharmaceuticals Ltd

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Quarta, 17 de Julho de 2024 (6 meses atrás) • Edgar (US Regulatory)
ASLAN Pharmaceuticals Announces it Has Filed for Voluntary Liquidation of Its Sole Operating Subsidiary and is Commencing Steps to Place Itself Into Voluntary Liquidation
Quarta, 17 de Julho de 2024 (6 meses atrás) • GlobeNewswire Inc.
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Segunda, 15 de Julho de 2024 (6 meses atrás) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Sexta, 14 de Junho de 2024 (7 meses atrás) • Edgar (US Regulatory)
Form F-3 - Registration statement by foreign private issuers
Quarta, 12 de Junho de 2024 (7 meses atrás) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Sexta, 31 de Maio de 2024 (7 meses atrás) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Quinta, 9 de Maio de 2024 (8 meses atrás) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Terça, 7 de Maio de 2024 (8 meses atrás) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Segunda, 11 de Março de 2024 (10 meses atrás) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Quarta, 14 de Fevereiro de 2024 (11 meses atrás) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Quarta, 24 de Janeiro de 2024 (11 meses atrás) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Segunda, 8 de Janeiro de 2024 (12 meses atrás) • Edgar (US Regulatory)

Mais Notícias de Aslan Pharmaceuticals Ltd

Seu Histórico Recente

BIT
P1OLD3
BNP Paribas Issuance
Delayed Upgrade Clock